ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CTXR Citius Pharmaceuticals Inc

0.8901
0.066 (8.01%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,277,931
Bid Price 0.89
Ask Price 0.9099
News -
Day High 0.9303

Low
0.60

52 Week Range

High
1.71

Day Low 0.805
Company Name Stock Ticker Symbol Market Type
Citius Pharmaceuticals Inc CTXR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.066 8.01% 0.8901 19:38:07
Open Price Low Price High Price Close Price Prev Close
0.81 0.805 0.9303 0.8973 0.8241
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
3,149 1,277,931 $ 0.8851153 $ 1,131,116 - 0.60 - 1.71
Last Trade Time Type Quantity Stock Price Currency
19:57:43 1 $ 0.9099 USD

Citius Pharmaceuticals Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
141.59M 159.09M - 0 -33.69M -0.21 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Citius Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CTXR Message Board. Create One! See More Posts on CTXR Message Board See More Message Board Posts

Historical CTXR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.7790.93030.72470.7925433621,2250.111114.26%
1 Month0.800.93030.650.747826586,3600.090111.26%
3 Months0.770.93030.600.7236465665,1770.120115.60%
6 Months0.68980.93030.600.7427041595,5810.200329.04%
1 Year1.001.710.601.061,054,600-0.1099-10.99%
3 Years1.84354.560.601.972,060,803-0.9534-51.72%
5 Years1.504.560.401.852,344,475-0.6099-40.66%

Citius Pharmaceuticals Description

Citius Pharmaceuticals, Inc. is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.

Your Recent History

Delayed Upgrade Clock